BIOMAT INDUCED PATHOPHYSIOLOGICAL CHANGES IN LEUKOCYTES
BIOMAT INDUCED PATHOPHYSIOLOGICAL CHANGES IN LEUKOCYTES
批准号:
2415579
负责人:
STUART L COOPER
金额:
$16.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 1999-04-30
关键词:
CD antigens biomaterial interface interaction blood coagulation cell cell interaction complement pathway fibrinolysis glass host organism interaction human tissue inflammation kallikreins kininogens leukocyte activation /transformation leukocyte adhesion molecules leukocytes phagocytosis platelet aggregation polyethylenes polymers polyurethanes silicone rubber surface property thrombosis video microscopy
中文摘要
描述:(改编自申请人的摘要)近年来
越来越多地使用涉及急性和慢性接触的治疗方法
材料和血液带来了对生物材料诱导的敏锐意识
发病率和死亡率。我们对促成因素的理解
这种病理生理变化涉及到各种不同的
生化系统仍然不完善。建议对此进行调查
特别是白细胞的作用和假设白细胞
参与是急性和慢性反应的一个重要因素。
到与血液接触的人造表面。具体来说,我们
假设(A)研究白细胞与
细胞成分将拓宽我们对血栓形成的理解
关于生物材料和(B)诱导补体激活和
物质接触导致的白细胞功能损害主要是
对后续炎症反应和设备的影响
相关感染。
白细胞对人工表面的反应是复杂和多样的,
包括黏附、聚集、颗粒释放、细胞表达
表面标志物和促凝血活性、纤溶和
吞噬作用。建议使用以下方法调查这些响应
结合了新的和成熟的技术在一系列
具有良好特性的材料。聚乙烯、硅橡胶、玻璃和
在所有研究中,将使用聚亚安酯作为测试表面。
具有特定性能的改性聚氨酯可以选择性地
引出引言,展开研究。
确定白细胞与细胞成分的关系
特别是调查人员建议在一次
基础水平,参与血小板的受体-配体对-
利用封闭肽、二价阳离子与白细胞相互作用
耗尽和抗体。此外,调查人员提议
确定血小板-白细胞相互作用是否导致CD11/CD18
上调、组织因子上调与L选择素下调
通过定量和功能分析。白细胞间的相互作用
并将通过确定联系和补充制度进行评估
激肽释放酶抑制物复合体的形成,使激肽原减少
激肽原的凝血活性和裂解作用。激活
经典的补体途径将通过测量c1-c1来评估
缓蚀剂复合体,C4D和最终途径通过测定IC3b和
C5B-9。
除了参与血液接触反应之外
生物材料表面,白细胞的黏附和激活也
与设备相关感染的发病机制相关,一个重要的
死亡的来源。我们假设一种化合物的化学性质
人工表面可能直接或直接影响白细胞的反应
通过调节血液成分,如补体或
凝血因子。相伴的或随后的细菌
殖民可能会受到影响。调查人员提议调查
涉及细菌、白细胞和生物材料的复杂相互作用
使用视频显微镜。预计拟议的研究将
极大地提高了我们对白细胞在
生物材料引起的病理生理变化,并最终将
从而设计出更好的临床使用材料。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) In recent years the
increasing use of therapies involving both acute and chronic contact of
materials and blood have brought a keen awareness of biomaterial induced
morbidity and mortality. Our understanding of contributory factors to
such pathophysiological changes involving alterations to various
biochemical systems remains imperfect. It is proposed to investigate
specifically the role of leukocytes and postulate that leukocyte
involvement is a significant factor in the acute and chronic reactions
to an artificial surface in contact with blood. Specifically we
hypothesize that (a) studying the interactions of leukocytes with
cellular elements will broaden our understanding of thrombus formation
on biomaterials and (b) induction of complement activation and
impairment of leukocyte function consequent to material contact has major
implications for subsequent inflammation responses as well as device
related infections.
Leukocyte responses to artificial surfaces are complex and varied and
include adhesion, aggregation, granule release, expression of cell
surface markers and procoagulant activity, fibrinolysis and
phagocytosis. It is proposed to investigate these responses using a
combination of novel and well-established techniques on a series of
well-characterized materials. Polyethylene, silicone rubber, glass and
a polyurethane will be used as the test surfaces in all studies.
Modified polyurethanes with specific properties may be selectively
introduced to extend the study.
To determine the relationship between leukocytes and cellular elements
particularly platelets the investigators propose to investigate at a
fundamental level, the receptor-ligand pair involved in platelet-
leukocyte interactions using blocking peptides, divalent cation
depletion and antibodies. Further, the investigators propose to
determine if platelet-leukocyte interactions result in CD11/CD18
upregulation, tissue factor upregulation and L selectin down-regulation
by quantitative and functional assays. The interactions of leukocytes
and the contact and complement system will be evaluated by determining
the formation of kallikrein-inhibitor complexes, decreases in kininogen
coagulant activity and cleavage of kininogen. Activation of the
classical complement pathway will be evaluated by measuring C1-C1
inhibitor complexes, C4d and the final pathway by measuring iC3b and
C5b-9.
In addition to being involved in the blood contacting response to
biomaterial surfaces, leukocyte adhesion and activation are also
relevant for the pathogenesis of device related infections, a significant
source of mortality. We hypothesize that the chemical properties of an
artificial surface may affect leukocyte responses either directly or
through the modulation of blood components such as complement or
coagulation factors. Concomitantly or subsequently bacteria
colonization may be affected. The investigators propose to investigate
the complex interactions involving bacteria, leukocytes and biomaterials
using video microscopy. It is expected that the proposed study will
significantly enhance our understanding of the role of leukocytes in
pathophysiological changes induces by biomaterials and will ultimately
lead to the design of better materials for clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CellTrap: A novel solid phase platform for analysis of stem/progenitor cells
-
批准号:7942924
-
项目类别:
-
资助金额:$65.84万
-
财政年份:2009
-
负责人:STUART L COOPER
-
依托单位:
CellTrap: A novel solid phase platform for analysis of stem/progenitor cells
-
批准号:7855060
-
项目类别:
-
资助金额:$67.67万
-
财政年份:2009
-
负责人:STUART L COOPER
-
依托单位:
INFLAMATION AND INFECTION ON BIOMATERIALS
-
批准号:2472603
-
项目类别:
-
资助金额:$11.08万
-
财政年份:1998
-
负责人:STUART L COOPER
-
依托单位:
BIOMAT INDUCED PATHOPHYSIOLOGICAL CHANGES IN LEUKOCYTES
-
批准号:2223476
-
项目类别:
-
资助金额:$16.84万
-
财政年份:1991
-
负责人:STUART L COOPER
-
依托单位:
MECHANISMS OF DAMAGE CAUSED BY CARDIOPULMONARY BYPASS
-
批准号:3366411
-
项目类别:
-
资助金额:$22.03万
-
财政年份:1991
-
负责人:STUART L COOPER
-
依托单位:
MECHANISMS OF DAMAGE CAUSED BY CARDIOPULMONARY BYPASS
-
批准号:2223474
-
项目类别:
-
资助金额:$21.76万
-
财政年份:1991
-
负责人:STUART L COOPER
-
依托单位:
MECHANISMS OF DAMAGE CAUSED BY CARDIOPULMONARY BYPASS
-
批准号:3366413
-
项目类别:
-
资助金额:$23.06万
-
财政年份:1991
-
负责人:STUART L COOPER
-
依托单位:
MECHANISMS OF DAMAGE CAUSED BY CARDIOPULMONARY BYPASS
-
批准号:3366410
-
项目类别:
-
资助金额:$18.25万
-
财政年份:1991
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337480
-
项目类别:
-
资助金额:$12.57万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337476
-
项目类别:
-
资助金额:$20.9万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337478
-
项目类别:
-
资助金额:$22.49万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337475
-
项目类别:
-
资助金额:$12.83万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337481
-
项目类别:
-
资助金额:$13.02万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337482
-
项目类别:
-
资助金额:$13.92万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337477
-
项目类别:
-
资助金额:$20.4万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
IN-VIVO EVALUATION OF SURFACE-INDUCED THROMBOGENESIS
-
批准号:3337479
-
项目类别:
-
资助金额:$13.13万
-
财政年份:1979
-
负责人:STUART L COOPER
-
依托单位:
PROTEIN AND THROMBUS DEPOSITION ON VASCULAR GRAFTS
-
批准号:3336329
-
项目类别:
-
资助金额:$14.5万
-
财政年份:1978
-
负责人:STUART L COOPER
-
依托单位:
PROTEIN AND THROMBUS DEPOSITION ON VASCULAR GRAFTS
-
批准号:3336327
-
项目类别:
-
资助金额:$14.14万
-
财政年份:1978
-
负责人:STUART L COOPER
-
依托单位:
PROTEIN AND THROMBUS DEPOSITION ON VASCULAR GRAFTS
-
批准号:3336325
-
项目类别:
-
资助金额:$14.29万
-
财政年份:1978
-
负责人:STUART L COOPER
-
依托单位:
PROTEIN AND THROMBUS DEPOSITION ON VASCULAR GRAFTS
-
批准号:3336330
-
项目类别:
-
资助金额:$14.61万
-
财政年份:1978
-
负责人:STUART L COOPER
-
依托单位: